This tutorial will illustrate how to:

 

Note: the workflow described below is enabled in Partek Genomics Suite (PGS) version 7.0. Please contact the Partek Licensing Team at licensing@partek.com to request this version or update the software release via Help > Check for Updates from the main command line. The screenshots shown below may vary across platforms and across different versions of PGS.

 

Description of the Data Set

Down syndrome is caused by an extra copy of all or part of chromosome 21; it is the most common non-lethal trisomy in humans. The study used in this tutorial revealed a significant upregulation of chromosome 21 genes at the gene expression level in individuals with Down syndrome; this dysregulation was largely specific to chromosome 21 only and not to any other chromosomes. This experiment was performed using the Affymetrix GeneChip™ Human U133A arrays. It includes 25 samples taken from 10 human subjects and 4 different tissues.

The raw data for this study is available as experiment number GSE1397 in the Gene Expression Omnibus: http://www.ncbi.nlm.nih.gov/geo/.

Data and associated files for this tutorial can be downloaded by going to Help > On-line Tutorials from the PGS main menu. The data can also be downloaded directly from: http://www.partek.com/Tutorials/microarray/Gene_Expression/Down_Syndrome/Down_Syndrome-GE.zip.

Importing Affymetrix CEL Files

Download the data from the Partek® site to your local disk. The zip file contains both data and annotation files.

Figure 1: Selecting the gene expression workflow

Figure 2: Selecting the folder and CEL files for the experiment

 

Figure 3: Import Affymetrix CEL Files dialog

Figure 4: Advanced Import Options

 

PGS will automatically assign the annotation files according to the chip type stored in the .CEL files. If the annotation files are not available in the library directory, PGS will automatically download them and store them in the Default Library File Folder.

Figure 5: 

Figure 6: 

 After importing the .CEL files has finished, the result file will open in PGS as a spreadsheet named 1 (Down_Syndrome-GE). The spreadsheet should contain 25 rows representing the micoarray chips (samples) and over 22,000 columns representing the probe sets (genes) (Figure 7). 

Figure 7: Viewing the main or top-level spreadsheet with imported .CEL files

For additional information on importing data into PGS, see Chapter 4 Importing and Exporting Data in the Partek User’s Manual. The User’s Manual is available from the Partek Genomic Suite menu from Help> User’s Manual. The FAQ (Help > On-line Tutorials > FAQ) may also be helpful. As this tutorial only addresses some topics, you may need to consult the User’s Manual for additional information about other useful features.

It is recommended that you are familiar with Chapter 6 The Pattern Visualization System of the user manual before going through the next section of the tutorial. 

Adding Sample Information

Twenty-five CEL files (samples) have been imported into PGS as shown in Figure 8. Sample information must be added to define the grouping and the goals of the experiment.

 

In this tutorial, the file name (e.g., Down Syndrome-Astrocyte-748-Male-1-U133A.CEL) contains the information about a sample and is separated by hyphens (-). Choosing to split the file name by delimiters will separate the categories into different columns as shown in Figure 11.



Figure 8: Configuring the Sample Information Creation dialog

Figure 9: Changing column properties

Note: More details on Random vs. Fixed Effects can be found later in this tutorial under the section Identifying Differentially Expressed Genes using the ANOVA.

Exploratory Data Analysis

At this point in analysis, you would explore the data preliminarily. Do the genes you expected to be differentially regulated appear to have larger or smaller intensity values?  Do similar samples resemble each other? 

The latter question can be explored using Principal Components Analysis (PCA), an excellent method for reducing and visualizing high-dimensional data.

Figure 10: PCR Scatter Plot tab

In the scatter plot, each point represents a chip (sample) and corresponds to a row on the top-level spreadsheet. The color of the dot represents the type of the sample; red represents a normal sample and blue represents a Down syndrome sample. Points that are close together in the plot have similar intensity values across the probe sets on the whole chip (genome), and points that are far apart in the plot are dissimilar

As you can see from rotating the plot, there is no clear separation between Down syndrome and normal samples in this data since the red and blue samples are not separated in space. However, there are other factors that may separate the data.

Figure 11: Configuring the PCA scatter plot: Color by Tissue, size by Type

Notice now that the data are clustered by different tissues (Figure 12). 

Figure 12: Configured PCA scatter plot

By rotating this PCA plot, you can see that the data is separated by tissues, and within some of the tissues, the Down syndrome samples and normal samples are separated. For example, in the Astrocyte and Heart tissues, the Down syndrome samples (small dots) are on the left, and the normal samples (large dots) are on the right (Figure 13).

Figure 13: PCA scatter plot with ellipses, rotated to show separation by Type 

PCA is an example of exploratory data analysis and is useful for identifying outliers and major effects in the data. From the scatter plot, you can see that the tissue is the biggest source of variation. There are many genes that express differently between the 4 tissues, but not as many genes that express differently between type (Down syndrome and normal) across the whole chip (genome).

The next step is to draw a histogram to examine the samples. Select Plot Sample Histogram in the QA/QC section of the Gene Expression workflow to generate the Histogram tab as shown in Figure 18.

Figure 14: Histogram tab 

The histogram plots one line for each of the samples with the intensity of the probes graphed on the X-axis and the frequency of the probe intensity on the Y-axis. This allows you to view the distribution of the intensities to identify any outliers. In this dataset, all the samples follow the same distribution pattern indicating that there are no obvious outliers in the data. As demonstrated with the PCA plot, if you click on any of the lines in the histogram, the corresponding row will be highlighted in the spreadsheet 1 (Down_Syndrome-GE). You can also change the way the histogram displays the data by clicking on the Plot Properties button. Explore these options on your own.

The decision to discard any samples would be based on information from the PCA plot, sample histogram plot, and QC metrics. To discard a sample and renormalize the data (without the effects of the outlier), start over with importing samples and omit the outlier sample(s) during the .CEL file import.

 

Identifying Differentially Expressed Genes using the ANOVA

Analysis of variance (ANOVA) is a very powerful technique for identifying differentially expressed genes in a multi-factor experiment such as this one. In this data set, the ANOVA will be used to generate a list of genes that are significantly different between Down syndrome and normal with an absolute difference bigger than 1.3 fold.

The ANOVA model should include Type since it is the primary factor of interest. From the exploratory analysis using the PCA plot, we observed that tissue is a large source of variation; therefore, tissue should be included in the model. In the experiment, multiple samples were taken from the same subject, so Subject must be included in the model. If Subject were excluded from the model, the ANOVA assumption that samples within groups are independent will be violated. Additionally, the PCA scatter plot showed that the Downs syndrome and normal separated within tissue type, so the Type*Tissue interaction should be included in the model.